Azione LONZA GROUP AG
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati
Strumento inattivo

Società Lonza Group AG Swiss Exchange

Azioni

CH0013841017

Biotecnologia

Tempo reale stimato Cboe Europe
Altri mercati azionari
 16:19:35 12/06/2024
491,2 CHF 0,00% Grafico intraday di Lonza Group AG
31/05 OPINIONI DEGLI ANALISTI DEL GIORNO : Italgas,Telecom Italia, Swisscom, Generali, Centrica, Buzzi, Lonza, Ahold, Sacyr, Richemont... Our Logo
31/05 Borsa di Italia: Ultimi ostacoli prima del taglio dei tassi? Our Logo

Attività

Lonza Group AG è uno dei leader mondiali nello sviluppo, produzione e commercializzazione di prodotti chimici. Le vendite nette sono suddivise per famiglia di prodotti e servizi come segue:
- biofarmaci (52,6%): sintesi esclusive, prodotti di fermentazione microbiologica, colture cellulari di mammiferi, ecc;
- capsule e soluzioni di dosaggio per biofarmaci, farmaci e prodotti nutrizionali (20,3%). Inoltre, il gruppo offre ingredienti nutrizionali;
- sostanze farmacologiche a piccole molecole (13,2%);
- tecnologie e piattaforme per i processi di fabbricazione e la produzione di terapie cellulari e geniche (11,1%);
- altro (2,8%).
Le vendite nette sono distribuite geograficamente come segue: Svizzera (16%), Europa (29,8%), Stati Uniti (38,8%), Americhe (3%), Giappone (3,7%), Cina (2,6%), Asia (5,8%) e altro (0,3%).

Vendite per attività

CHF in Milioni2022Peso2023Peso Delta
Biologics
55,4 %
3 274 52,6 % 3 719 55,4 % +13,59%
Capsules & Health Ingredients
17,3 %
1 266 20,3 % 1 161 17,3 % -8,29%
Small Molecules
13,4 %
819 13,2 % 901 13,4 % +10,01%
Cell & Gene
10,4 %
693 11,1 % 696 10,4 % +0,43%
Corporate/Eliminations
3,6 %
171 2,7 % 240 3,6 % +40,35%

Vendite per regione

CHF in Milioni2022Peso2023Peso Delta
United States
31,8 %
2 415 38,8 % 2 136 31,8 % -11,55%
Switzerland
17,4 %
996 16,0 % 1 168 17,4 % +17,27%
Japan
8,1 %
227 3,6 % 544 8,1 % +139,65%
Ireland
5,5 %
343 5,5 % 368 5,5 % +7,29%
Belgium
5,1 %
302 4,9 % 341 5,1 % +12,91%
Denmark
4,8 %
158 2,5 % 322 4,8 % +103,80%
Germany
4,5 %
224 3,6 % 302 4,5 % +34,82%
Rest of Europe
2,9 %
207 3,3 % 195 2,9 % -5,80%
China
2,6 %
161 2,6 % 172 2,6 % +6,83%
United Kingdom
2,5 %
139 2,2 % 171 2,5 % +23,02%
Singapore
2,0 %
113 1,8 % 137 2,0 % +21,24%
Sweden
1,8 %
143 2,3 % 123 1,8 % -13,99%
France
1,7 %
116 1,9 % 111 1,7 % -4,31%
South Korea
1,4 %
141 2,3 % 97 1,4 % -31,21%
Canada
1,3 %
63 1,0 % 90 1,3 % +42,86%
Netherlands
1,3 %
132 2,1 % 88 1,3 % -33,33%
Brazil
1,1 %
49 0,8 % 71 1,1 % +44,90%
Italy
0,8 %
41 0,7 % 52 0,8 % +26,83%
India
0,6 %
42 0,7 % 42 0,6 % 0,00%
Spain
0,6 %
41 0,7 % 40 0,6 % -2,44%
Mexico
0,5 %
34 0,5 % 33 0,5 % -2,94%
Rest of Asia
0,4 %
36 0,6 % 29 0,4 % -19,44%
Rest of Latin America
0,4 %
38 0,6 % 26 0,4 % -31,58%
Australia & New Zealand
0,2 %
21 0,3 % 16 0,2 % -23,81%
Thailand
0,2 %
15 0,2 % 15 0,2 % 0,00%
Indonesia
0,2 %
16 0,3 % 14 0,2 % -12,50%
Czech Republic
0,2 %
7 0,1 % 11 0,2 % +57,14%
Other Countries
0,0 %
2 0,0 % 2 0,0 % 0,00%
Rest of North and Central America
0,0 %
1 0,0 % 1 0,0 % 0,00%

Dirigenti

Dirigenti TitoloEtàDa
Albert Baehny CEO
 Chief Executive Officer 72 25/04/17
Philippe Deecke DFI
 Director of Finance/CFO 52 01/12/21
Maria Nunez COO
 Chief Operating Officer 55 01/08/22
Lyle Wheeler IRC
 Investor Relations Contact - -

Amministratori

Amministratori TitoloEtàDa
Barbara Richmond BRD
 Director/Board Member 63 16/04/14
Jürgen B. Steinemann BRD
 Director/Board Member 66 16/04/14
Marion Helmes BRD
 Director/Board Member 58 05/05/22
Albert Baehny CEO
 Chief Executive Officer 72 25/04/17
Christoph Mäder BRD
 Director/Board Member 64 26/04/16
Roger Nitsch BRD
 Director/Board Member 63 01/05/22
Angelica Kohlmann BRD
 Director/Board Member 64 04/05/18
Olivier Verscheure BRD
 Director/Board Member 52 04/05/18

Classe di azioni

VotoQuantitàFlottanteAutocontrolloFlottante totale
Azione A 1 74 468 752 72 076 913 ( 96,79 %) 2 352 163 ( 3,159 %) 96,79 %

Azionisti

NomeAzioni%Valorizzazione
LONZA GROUP AG
3,159 %
2 352 163 3,159 % 1 268 M CHF
Norges Bank Investment Management
2,990 %
2 226 615 2,990 % 1 200 M CHF
Carmignac Gestion Luxembourg SA (UK)
0,3586 %
267 011 0,3586 % 144 M CHF
Seilern Investment Management Ltd.
0,2488 %
185 286 0,2488 % 100 M CHF
Caixabank Asset Management SGIIC SA
0,2218 %
165 186 0,2218 % 89 M CHF
Eurizon Capital SGR SpA
0,1968 %
146 581 0,1968 % 79 M CHF
Union Bancaire Privée, UBP SA
0,1937 %
144 255 0,1937 % 78 M CHF
Crédit Mutuel Asset Management SA
0,1921 %
143 064 0,1921 % 77 M CHF
CAPFI DELEN Asset Management NV
0,1732 %
128 948 0,1732 % 70 M CHF
Rathbones Asset Management Ltd.
0,1669 %
124 272 0,1669 % 67 M CHF
NomeAzioni%Valorizzazione
SBI Funds Management Ltd.
0,4999 %
3 723 000 0,4999 % 201 M CHF
Vigilant Capital Management LLC (Old)
0,0323 %
240 842 0,0323 % 13 M CHF
Zevin Asset Management LLC
0,0165 %
123 110 0,0165 % 7 M CHF
Torray Investment Partners LLC
0,0147 %
109 698 0,0147 % 6 M CHF
Madison Asset Management LLC
0,008090 %
60 246 0,008090 % 3 M CHF
Domini Impact Investments LLC
0,003384 %
25 200 0,003384 % 1 M CHF
RhumbLine Advisers LP
0,001861 %
13 855 0,001861 % 747 006 CHF
SkyView Investment Advisors LLC
0,001081 %
8 048 0,001081 % 433 916 CHF
Henry James International Management, Inc.
0,000996 %
7 420 0,000996 % 400 057 CHF
GAMMA Investing LLC
0,000120 %
891 0,000120 % 48 039 CHF

Partecipazioni

NomeAzioni%Valorizzazione
LONZA GROUP AG
3.16%
 2 352 163 3.16% 1 268 183 853 $

Coordinate società

Lonza Group AG

Muenchensteinerstrasse 38

4002, Basel

+41 61 316 81 11

http://www.lonza.com
Indirizzo Lonza Group AG

Società del gruppo

NomeCategoria e settore
Lonza Biologics Plc
Logo Lonza Biologics Plc

Lonza Biologics Plc

Miscellaneous Commercial ServicesCommercial Services

Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom.

Miscellaneous Commercial Services
Lonza Swiss Finanz AG
Logo Lonza Swiss Finanz AG

Lonza Swiss Finanz AG

Finance/Rental/LeasingFinance

Lonza Swiss Finanz AG engages in the provision of financing services within the companies of Lonza Group AG. It also invests in domestic and foreign industrial and commercial firms. The company was founded on December 23, 1974 and is headquartered in Basel, Switzerland.

Finance/Rental/Leasing
Capsugel Plöermel SASU
Logo Capsugel Plöermel SASU

Capsugel Plöermel SASU

BiotechnologyHealth Technology

Capsugel Plöermel SASU designs and manufactures biopharmaceuticals. The company is headquartered in Ploermel, France.

Biotechnology
Arch Chemicals Ltd.
Logo Arch Chemicals Ltd.

Arch Chemicals Ltd.

Chemicals: SpecialtyProcess Industries

Arch Chemicals Ltd. engages in the manufacture of inorganic basic chemicals. Its products are mainly used in the swimming pool for body treatment. The company was founded on February 24, 1978 and is headquartered in Castleford, the United Kingdom.

Chemicals: Specialty
Capsugel France SAS
Logo Capsugel France SAS

Capsugel France SAS

Apparel/Footwear RetailRetail Trade

Capsugel France SAS manufactures & distributes clothes and clothing accessories. The company was founded in 1970 and is headquartered in Colmar, France.

Apparel/Footwear Retail
Capsugel Belgium SA
Logo Capsugel Belgium SA

Capsugel Belgium SA

Pharmaceuticals: MajorHealth Technology

Capsugel Belgium NV provides dosage forms and solutions. The firm also sells equipment for filling empty and liquid capsules and equipment for sealing liquid capsules. The company was founded on October 1, 1961 and is headquartered in Bornem, Belgium.

Pharmaceuticals: Major
Innovative Water Care Europe SAS
Logo Innovative Water Care Europe SAS

Innovative Water Care Europe SAS

Specialty StoresRetail Trade

Innovative Water Care Europe SAS manufactures basic organic chemicals. The company was founded on September 17, 1982 and is headquartered in Amboise, France.

Specialty Stores
Hickson Ltd.
Logo Hickson Ltd.

Hickson Ltd.

Miscellaneous Commercial ServicesCommercial Services

Founded in 1937, Hickson Ltd. is a business consulting British company that provides consulting services. The company is based in Castleford, UK and is part of Lonza Group AG.

Miscellaneous Commercial Services
Arch UK Biocides Ltd.
Logo Arch UK Biocides Ltd.

Arch UK Biocides Ltd.

Household/Personal CareConsumer Non-Durables

Part of Lonza Group AG, Arch UK Biocides Ltd. is a provider of integrated healthcare solutions to the pharmaceutical, biotech, and specialty ingredients markets. The company is based in Castleford, UK, and offers careers in various disciplines such as bioengineering and chemistry. Lonza optimizes scientific innovation and manufacturing technology to enable its customers to serve their patients and consumers. Lonza's quality management is committed to meeting all specifications and fulfilling customer needs and expectations. Founded in 2003, the British company's solutions aim to improve life quality by preventing illness, enabling healthier lifestyles, and supporting a safe environment.

Household/Personal Care

Settore

Sanità
Biotecnologia/Farmaceutici
Biotecnologia e ricerca medica
Biotecnologia
Biotecnologia e ricerca medica - Altri

Vendite per attività

Vendite per regione

Settore Biotecnologia e ricerca medica - Altri

Variaz. 1 gen. Capi.
MODERNA, INC. Azione Moderna, Inc.
+43,41% 56,87 Mrd
IQVIA HOLDINGS INC. Azione Iqvia Holdings Inc.
-6,71% 39,27 Mrd
CELLTRION, INC. Azione Celltrion, Inc.
-4,42% 28,73 Mrd
ICON PUBLIC LIMITED COMPANY Azione ICON Public Limited Company
+13,25% 26,21 Mrd
ALNYLAM PHARMACEUTICALS, INC. Azione Alnylam Pharmaceuticals, Inc.
-16,97% 19,79 Mrd
MEDPACE HOLDINGS, INC. Azione Medpace Holdings, Inc.
+31,82% 12,28 Mrd
UNITED THERAPEUTICS CORPORATION Azione United Therapeutics Corporation
+27,25% 12,23 Mrd
BIO-TECHNE CORPORATION Azione Bio-Techne Corporation
-0,17% 12,12 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Azione Charles River Laboratories International, Inc.
-9,38% 10,84 Mrd
Biotecnologia e ricerca medica - Altri
  1. Borsa valori
  2. Azioni
  3. Azione LONN
  4. Azione
  5. Società Lonza Group AG